The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
Sodium O-2-(hexadecyloxy)-3-methoxypropyl O-hydrogenphosphorothioate ID: ALA2335049
PubChem CID: 71569053
Max Phase: Preclinical
Molecular Formula: C20H42NaO5PS
Molecular Weight: 426.60
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CCCCCCCCCCCCCCCCOC(COC)COP([O-])(O)=S.[Na+]
Standard InChI: InChI=1S/C20H43O5PS.Na/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-24-20(18-23-2)19-25-26(21,22)27;/h20H,3-19H2,1-2H3,(H2,21,22,27);/q;+1/p-1
Standard InChI Key: QZHWXBYUIWJGDD-UHFFFAOYSA-M
Molfile:
RDKit 2D
28 26 0 0 0 0 0 0 0 0999 V2000
7.9532 -2.7240 0.0000 Na 0 0 0 0 0 15 0 0 0 0 0 0
5.5676 -1.9109 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
5.9804 -2.6208 0.0000 P 0 0 0 0 0 0 0 0 0 0 0 0
6.3888 -1.9084 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.4433 -3.0335 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.1510 -2.6249 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8587 -3.0335 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5664 -2.6249 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2742 -3.0335 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.6896 -3.0335 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.8587 -3.8507 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.5664 -4.2593 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2742 -3.8507 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7356 -2.6249 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9819 -4.2593 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6896 -3.8507 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3973 -4.2593 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1050 -3.8507 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8127 -4.2593 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5204 -3.8507 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2281 -4.2593 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9358 -3.8507 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6435 -4.2593 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3512 -3.8507 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0589 -4.2593 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7667 -3.8507 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4744 -4.2593 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1821 -3.8507 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3 2 2 0
4 3 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 3 1 0
3 10 1 0
7 11 1 0
11 12 1 0
12 13 1 0
5 14 1 0
13 15 1 0
15 16 1 0
16 17 1 0
17 18 1 0
18 19 1 0
19 20 1 0
20 21 1 0
21 22 1 0
22 23 1 0
23 24 1 0
24 25 1 0
25 26 1 0
26 27 1 0
27 28 1 0
M CHG 2 1 1 10 -1
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 426.60Molecular Weight (Monoisotopic): 426.2569AlogP: 5.73#Rotatable Bonds: 21Polar Surface Area: 68.15Molecular Species: ACIDHBA: 4HBD: 2#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 1CX Acidic pKa: 2.18CX Basic pKa: ┄CX LogP: 6.87CX LogD: 3.67Aromatic Rings: ┄Heavy Atoms: 27QED Weighted: 0.18Np Likeness Score: 0.56
References 1. Jiang G, Inoue A, Aoki J, Prestwich GD.. (2013) Phosphorothioate analogs of sn-2 radyl lysophosphatidic acid (LPA): metabolically stabilized LPA receptor agonists., 23 (6): [PMID:23395664 ] [10.1016/j.bmcl.2013.01.002 ]